OncoSec Medical Statistics
Total Valuation
OncoSec Medical has a market cap or net worth of 6. The enterprise value is 4.78 million.
| Market Cap | 6 |
| Enterprise Value | 4.78M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
OncoSec Medical has 5.96 million shares outstanding.
| Shares Outstanding | 5.96M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +44.52% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 10.28% |
| Float | 5.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.16 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.19 |
Financial Position
The company has a current ratio of 0.89
| Current Ratio | 0.89 |
| Quick Ratio | 0.51 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.34 |
| Interest Coverage | -626.33 |
Financial Efficiency
Return on equity (ROE) is -410.17% and return on invested capital (ROIC) is -119.93%.
| Return on Equity (ROE) | -410.17% |
| Return on Assets (ROA) | -92.84% |
| Return on Capital (ROIC) | -119.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -716,728 |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.93% in the last 52 weeks. The beta is -17.99, so OncoSec Medical's price volatility has been lower than the market average.
| Beta (5Y) | -17.99 |
| 52-Week Price Change | -99.93% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 48.85 |
| Average Volume (20 Days) | 4,365 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -32.65M |
| Pretax Income | -32.72M |
| Net Income | -29.39M |
| EBITDA | -32.40M |
| EBIT | -32.65M |
| Earnings Per Share (EPS) | -14.77 |
Balance Sheet
The company has 3.68 million in cash and 8.46 million in debt, giving a net cash position of -4.78 million or -0.80 per share.
| Cash & Cash Equivalents | 3.68M |
| Total Debt | 8.46M |
| Net Cash | -4.78M |
| Net Cash Per Share | -0.80 |
| Equity (Book Value) | -5.49M |
| Book Value Per Share | -1.85 |
| Working Capital | -789,468 |
Cash Flow
In the last 12 months, operating cash flow was -24.99 million and capital expenditures -15,955, giving a free cash flow of -25.01 million.
| Operating Cash Flow | -24.99M |
| Capital Expenditures | -15,955 |
| Free Cash Flow | -25.01M |
| FCF Per Share | -4.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OncoSec Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.17% |
| Shareholder Yield | -13.17% |
| Earnings Yield | -1,477,410,900.00% |
| FCF Yield | -419,451,864.71% |
Stock Splits
The last stock split was on November 9, 2022. It was a reverse split with a ratio of 0.0454545.
| Last Split Date | Nov 9, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0454545 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |